This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Konica Minolta, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Minoru Miyashita - Innovator in Cancer Research
Introduction
Minoru Miyashita, located in Sendai, Japan, stands out as a pioneering inventor focused on advancements in cancer research. He holds a single patent that showcases his commitment to improving treatment predictions for breast cancer patients through innovative methodologies.
Latest Patents
Miyashita's notable patent is titled "Test support method for supporting prediction of pathological complete response (pCR) using fluorescent nanoparticles." This invention outlines a groundbreaking approach to predict whether patients undergoing preoperative chemotherapy with anticancer drugs will achieve a pathological complete response. The methodology involves using a sample from the patient, specifically a breast cancer tissue section, to conduct analyses that leverage fluorescent nanoparticles. The steps include acquiring fluorescence images of the tissue section, determining expression levels of breast cancer-related proteins, and performing analyses to yield predictive information about pCR.
Career Highlights
Minoru Miyashita's career has been marked by his affiliation with Konica Minolta, Inc., where he has been integral to research and development in the field of cancer diagnostics. His innovative approach has facilitated new ways of understanding cancer treatment responses, demonstrating his impact as a leading inventor in medical technology.
Collaborations
Miyashita collaborates with esteemed colleagues Hideki Gouda and Masaru Takahashi, contributing to a dynamic team focused on leveraging technology to transform cancer care. Their collective expertise strengthens the research outcomes and enhances the potential for future innovations within the company.
Conclusion
With a commitment to advancing cancer treatment predictions, Minoru Miyashita exemplifies the spirit of innovation in the medical field. His dedicated work at Konica Minolta, Inc. and his pioneering patent serve as a testament to his contributions as an inventor, ultimately aiming to improve patient outcomes in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile